Othera, which was founded in 2002, recently closed on $16 million in venture capital financing to develop novel drugs to treat and prevent such eye diseases as cataracts, age-related macular degeneration and glaucoma. Its lead drug in development is an eye-drop formulation to prevent or delay cataract formation.
Whiteland is home to several pharmaceutical and technology firms. This August Widener University opened a new campus there devoted to retirees and students age 50 and older.
Brad Spiegel, president of Conshohocken-based Skyline Commercial Real Estate, represented Othera in the lease negotiations, working with Matt McDevitt, a principal of the building owner, Mockingbird Exton LP. Skyline specializes in only representing tenants.
© Touchpoint Markets, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more inforrmation visit Asset & Logo Licensing.